Distinct Tumor and Metastatic Collagen Microenvironments: Divergent Targeting Approaches
- Institution
- METHODIST HOSPITAL RESEARCH INSTITUTE, TX
- Principal investigator
- Keith Syson Chan
- Funding
- $386K
- Duration
- 2013–2026
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY Metastatic progression of the primary tumor accounts for the majority of cancer deaths. While the initial steps of the metastatic cascade are rather well defined, identification of targets to block this process remains a major clinical challenge. Previous studies have elegantly investigated the mechanistic contribution of tumor cell intrinsic properties that promote metastasis in bladder urothelial carcinomas. However, the functional significance of the tumor microenvironment and its contribution to this complicated process is not well characterized, and therefore, warrants investigation. The long-term goal of this renewal application is to continue explore how collagens—a major extracellular matrix component of the microenvironment—act as a ligand to mediate crosstalk with their receptor on tumor cells to facilitate the metastatic cascade. We will investigate the downstream regulatory mechanisms of collagen receptor signaling in both the primary tumor and metastatic sites, and to exploit these regulatory processes as a revolutionizing approach to target metastases. Such innovative approaches to perturb collagen-cancer crosstalk—not only at the primary tumor but also at the metastatic niche—will move the field forward by providing a new conception in metastatic disease management, and likely extend beyond bladder carcinomas to other cancer types.
LOADING MOONBASE SCORE
Questions for METHODIST HOSPITAL RESEARCH INSTITUTE
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Methodist Hospital Research InstituteNot yet scored
The stromal microenvironment as a co-organizer of bladder carcinogenesis and progression
Keith Syson Chan · $1.6M · 2022–2027
- NIH · Methodist Hospital Research InstituteNot yet scored
Administrative Core
Keith Syson Chan · $312K · 2022–2027
- NIH · Methodist Hospital Research InstituteNot yet scored
Project 1
Keith Syson Chan · $356K · 2022–2027